Gallium (68Ga) PSMA-11 (gozetotide) prepared using PSMA-11 Sterile Cold Kit

DRUG2 trials

Sponsors

Bayer Consumer Care AG, Bayer AG, Stichting Radboud universitair medisch centrum

Conditions

Biochemically recurrent prostate cancerMetastatic renal cell carcinoma

Phase 3

(21492 ARASTEP) A randomized, double-blind, placebo-controlled Phase 3 study of darolutamide plus androgen deprivation therapy (ADT) compared with placebo plus ADT in patients with high-risk biochemical recurrence (BCR) of prostate cancer

Active, not recruitingCTIS2022-501343-33-00

Bayer Consumer Care AG, Bayer AGBiochemically recurrent prostate cancer

Start: 2023-10-18Target: 562Updated: 2026-01-21

Intrapatient comparison of 68Ga-gozetotide (PSMA) PET and 89Zr-girentuximab PET in clear cell renal cell carcinoma (ISEE-RCC)

RecruitingCTIS2024-514181-39-00

Stichting Radboud universitair medisch centrumMetastatic renal cell carcinoma

Start: 2025-09-23Target: 20Updated: 2025-02-25